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ABSTRACT 
The interaction between local and reflexive control of skin blood flow (SkBF) is 
unclear. This thesis isolated the roles of rectal (Tre) and local (Tloc) temperature on 
forearm SkBF regulation at normal and elevated body temperatures, and to investigate 
the interaction between local and reflexive SkBF control. While either normothermic (Tre 
~37.0°C) or hyperthermic (∆Tre +1.1°C), SkBF was assessed on the dorsal aspect of each 
forearm in 10 participants while Tloc was manipulated in an A-B-A-B fashion between 
neutral (33.0°C) and hot (38.5°C). Finally, local heating to 44°C was performed to elicit 
maximal SkBF. Data are presented as a percentage of maximal cutaneous vascular 
conductance (CVC), calculated as laser-Doppler flux divided by mean arterial pressure. 
Tloc manipulations performed during normothermia had significantly greater effects on 
CVC than during hyperthermia. The decreased modification to SkBF from the Tloc 
changes during hyperthermia suggests that strong reflexive vasodilation attenuates local 
SkBF control mechanisms. 
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CHAPTER ONE: INTRODUCTION 
Changes in skin blood flow (SkBF) are one of the primary thermoregulatory 
responses in humans. The cutaneous vasculature responds in a strong and dynamic 
fashion depending on the environmental conditions, which can range from negligible 
flow values when exposed to cold stress, to up to 8 L·min-1 during heat stress (59, 90, 91) 
Changes in cutaneous circulation in nonglabrous (hairy) skin are mediated via two 
branches of the sympathetic nervous system (noradrenergic vasoconstrictor system and 
cholinergic vasodilator system), and a combination of local factors (12, 58, 59, 63). 
Research describing the responses of SkBF to thermal stress has been well documented 
(see Johnson et al., (59) for a comprehensive review), with core body temperature (Tc; 
(12, 63)), mean skin temperature (T̅sk; (59)), and local skin temperature (Tloc; (8, 45, 58)) 
being important afferents.  
Previous work has mainly focused on these thermal afferents individually (8, 26, 
42, 45, 64, 81, 114), and a few have attempted to isolate them (9, 29, 57, 86, 97). Prior 
work has been limited by the ability to control different afferents simultaneously, without 
using techniques that modify SkBF control. Indeed, studies aiming to separate the roles 
of reflexive and local SkBF control have either used exercise (86), which leads to an 
elevated internal (core) temperature threshold for the onset of vasodilation (60, 67), 
studied glabrous (non-hairy) skin (9, 24, 29, 33), did not maintain thermoneutrality in the 
limb (33, 97), or did not manipulate Tloc during distinct Tc phases to observe the 
interaction of the two control mechanisms (57). If thermoneutrality is not maintained, the 
thermal background may evoke local control mechanisms such as endothelial nitric oxide 
synthase (eNOS; (71)), norepinephrine (NE; (49)), neuropeptide-Y (NPY; (46)), 
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endothelial dependent hyperpolarizing factors (EDHFs; (8)) or a host of other local 
factors (59). Not controlling Tloc during heat stress allows for reflexive vasodilation to 
increase Tloc. Due to logistical issues controlling temperature, little work (29, 33, 57, 97, 
105) has been able to successfully isolate and quantify the relative contribution of 
peripheral (Tloc) or central (Tc) afferents regulating SkBF, while maintaining consistent 
thermal backgrounds. 
Research designs have successfully isolated Tc and Tloc while focusing on other 
physiological variables such as neuromuscular function (109), finger cold-induced 
vasodilation (CIVD) (24, 29), and metabolic heat production and circulating 
catecholamines (33). Thomas et al. (109) were able to increase Tc by ~2°C while 
clamping muscle and skin temperature of one leg at thermoneutral through ice packs, 
successfully isolating central and peripheral afferents governing neuromuscular function 
(109). The studies attempting to isolate SkBF afferents (9, 24, 29, 33, 57) suggest that the 
central afferents play a dominant role in regulating physiological variables more than 
peripheral afferents. Importantly, when thermoneutrality is maintained in one arm and 
Tloc is increased to 42.5°C in the other, passively heating participants caused equal 
cutaneous vasodilation to occur, indicating that central afferents have a predominant role 
during hyperthermia (57). Overall, however, the relative importance of local control of 
SkBF during thermal stress remains unclear.  
Therefore, the objective of this experiment was to isolate the roles of rectal 
temperature (Tre) and Tloc on forearm SkBF. This was achieved during both normo- and 
hyper-thermia (∆Tre +1.1°C) by alternating between a neutral (33.0°C) and hot (38.5°C) 
arm Tloc, while maintaining the other arm at thermoneutral (33.0°C). It is hypothesized 
  
 
3 
that: 1) Tloc will be the driving force behind cutaneous blood flow during normothermia, 
and 2) Tre will be the driving force for forearm SkBF during hyperthermia; SkBF will not 
respond to changes in Tloc. 
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CHAPTER TWO: LITERATURE REVIEW 
Alterations in SkBF are one of the primary thermoregulatory responses in humans 
(58, 59). SkBF responds in a strong and dynamic fashion depending on environmental 
conditions, ranging from almost zero when exposed to cold stress to 8 L·min-1 in cases of 
heat stress (90, 91, 105). Two branches of the sympathetic nervous system, an adrenergic 
vasoconstrictor and a nonadrenergic vasodilator branch control cutaneous circulation (12, 
43, 59). When a cold stimulus is applied to the skin, a decrease in blood flow termed 
reflexive vasoconstriction (59, 97) occurs in an attempt to maintain Tc at approximately 
37.0°C. If the cold stress is intense and long enough, SkBF will be reduced to almost zero 
in an attempt to minimize heat loss (59, 90, 91). During heat stress SkBF increases in an 
attempt to dissipate heat through convective heat loss (14, 111). There is a bi-phasic 
vasodilation response to local heating (see Fig. 1 below) that consists of an initial peak 
followed by a brief portion of nadir, then a sustained plateau before it dies away (3, 58, 
59).  
 
Figure 1. Biphasic response to local heating (Adapted from (58)). 
Initial Peak 
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Aside from thermoregulation, SkBF plays an integral role in blood pressure (BP) 
regulation through arterial baroreceptors (12, 21, 56, 62). Decreases in central blood 
volume occur during heat stress as the cutaneous circulation can receive as much as 60% 
of cardiac output (56, 90, 91). When baroreceptors detect that there is low central blood 
volume, peripheral vasoconstriction occurs in causing a redistribution of blood towards 
the brain, splanchnic and thoracic regions (12, 22). Activation of baroreceptors can occur 
due to changes in posture (upright vs. supine), which leads to peripheral vasoconstriction 
in both normo- and hyper-thermic conditions (12, 57, 62). Thermoregulatory and BP 
inputs can thus compete against each other to maintain Tc and central blood volume (21, 
56). This review will discuss the mechanisms involved in three sections of local and 
whole-body heating, as well as the relationship between core and peripheral skin 
temperature, the mechanisms involved, and how thermal homeostasis is maintained.  
2.1 Drugs used for Assessment of Skin Blood Flow 
This review will begin with a survey of common drugs that have been extensively 
used in SkBF literature to study the mechanisms controlling cutaneous circulation and its 
response to local and/or whole-body heating, as well as their two major delivery methods. 
These drugs have high specificity, enabling certain aspects of cutaneous circulation to be 
studied by abolishing, inhibiting or antagonizing different pathways (See Table 1 for a 
list of commonly used drugs to studying mechanisms of SkBF). For example, bretylium 
tosylate (BT) is taken up by sympathetic nerve endings, which inhibits the reuptake and 
further release of NE and other neurotransmitters, thus, abolishing sympathetic 
contribution to cutaneous circulation (38, 68). To assess sympathetic contribution of 
SkBF, BT is applied to an experimental site while a control site is left untreated, or 
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‘treated’ with the delivery vehicle to ensure that its effect on SkBF is taken into account. 
The difference in SkBF between the experimental and the control site allows for the 
contribution of the NE and co-neurotransmitters to be assessed (68).  
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Table 1. Common drugs used in skin blood flow work. 
Name (Abbreviation) Effect Mechanism 
Botulinum Toxin Abolish cholinergic nerve 
activity 
Presynaptically abolishes the 
release of acetylcholine and 
cotransimitters from 
cholinergic nerves (70) 
Bretylium tosylate  
(BT) 
Abolish sympathetic nerve 
activity 
Presynaptically blocks the 
release of NE and 
cotransmitters from the 
sympathetic nerves (38) 
N2-(diphenylacetyl)-N-
([4-
hydroxyphenyl]methyl)-
D-arginine amide  
(BIBP-3226) 
Prevents NPY from binding to 
Y1 receptor. Acts in part to 
abolish sympathetic 
vasoconstrictor response 
Postsynaptic blockade of 
NPY at Y1 receptors (46) 
Nitro-L-arginine methyl 
ester  
(L-NAME) 
Inhibits the production of NO Non-selective NOS inhibitor 
(69) 
Nω-amino-L-arginine 
(LNAA) 
Inhibits production of NO 
resulting from the eNOS 
isoform 
Selective eNOS inhibition 
(71) 
Nω-propyl-L-arginine 
(NPLA) 
Inhibits production of NO 
resulting from the nNOS 
isoform 
Selective nNOS inhibition 
(73) 
Propranolol (PRO) Prevents NE from binding to β 
adrenergic receptors. Acts in 
part to abolish sympathetic 
vasoconstrictor response 
Postsynaptic blockage of β 
adrenergic receptors (46) 
Sodium nitroprusside 
(SNP) 
Elicits a maximal vasodilation 
response 
Nitric oxide donor (34) 
Topical anesthetic 
(EMLA) 
Sensory nerve blockade Inhibits nerve impulses by 
blocking sodium channels 
(81) 
Yohimbine (YOH) Prevents NE from binding to α 
adrenergic receptors. Acts in 
part to abolish sympathetic 
vasoconstrictor response 
Postsynaptic blockade of α 
adrenergic receptors (46) 
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2.2 Methods to Introduce Drugs into Skin Microvasculature 
Microdialysis and iontophoresis are the two primary methods used to introduce 
pharmacological agents into the cutaneous circulation. These methods of introducing 
agents into the area do not have systemic effects and are highly localized. Other 
modalities to introduce drugs into the cutaneous vasculature are through a topical cream 
(i.e., EMLA) or injection (i.e., botulinum toxin). 
2.2.1 Microdialysis 
Microdialysis comprises of inserting a microdialysis fibre into the dermal layer of 
the skin, allowing for mechanistic investigations of the cutaneous circulation in vivo (2, 
40). Typically ice or a local anaesthetic is applied to temporarily anesthetise the skin 
before inserting the fibres. If ice or a local anaesthetic is not applied prior to inserting 
microdialysis fibres, peak cutaneous vascular conductance (CVC) response is attenuated 
(40). A 25-gauge needle is inserted into the dermal layer of the skin for approximately 
2.5 – 3.0 cm. The microdialysis fibre is then fed through the lumen of the needle and the 
needle is then removed from the skin leaving the microdialysis fibre in place (2, 40, 49, 
69). This protocol must be done 90 min before the experiment takes place to allow for the 
trauma to subside from inserting the fibres (2, 40). 
 
Figure 2. A representation of a microdialysis fibre. Drugs are typically dissolved in lactated 
Ringer's solutions and circulated through the fibre (69). 
  
 
9 
An advantage of microdialysis is that researchers are able to perform multiple 
interventions simultaneously due to the drugs’ highly localized effects, and it is common 
to have four fibres on one forearm spaced 3 – 5 cm apart during an experiment (40). This 
is advantageous as it is time and cost effective, participants serve as their own control, 
and eliminates day-to-day variability. Drugs must be dissolved in an electrolyte 
(Ringer’s) solvent in order to facilitate transportation in the microdialysis fibre as well as 
achieve the correct drug concentration. Ringer’s solution serves as the control as it allows 
researchers to compare the direct effect of the drugs compared to the vehicle, which has 
been demonstrated to elicit no effect on SkBF (69). Drugs perfuse out of the fibre 
following their concentration gradients and into the skin at the semi-permeable 
membrane of the microdialysis fibre (69). Since microdialysis uses the drugs’ 
concentrations to deliver it to the skin, larger and non-polar molecules can be delivered 
this way (which is an advantage over iontophoresis, discussed below). Intriguingly, an 
unexplored avenue is analysis on the subsequent neuropeptides that are in the perfusate 
due to their concentration gradient. Neuropeptides will move from areas of high 
concentration (tissue) to low concentration (microdialysis fibre), which then can be 
collected for subsequent analysis. 
When employing microdialysis, several significant limitations or considerations 
exist. The first most obvious disadvantage is that the needle insertion to the skin that can 
cause trauma to the dermal layer and lead to inflammation (2, 40). In support of this, peak 
CVC during whole-body heating is significantly lower when the fibre is inserted without 
temporarily anesthetising the skin with ice or a local anaesthetic (40). Second, the 
internal temperature when vasodilation begins is significantly higher when using 
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microdialysis (40), so care is needed in comparing microdialysis data to those using other 
SkBF manipulation techniques.  
2.2.2 Iontophoresis 
Iontophoresis is a non-invasive technique to apply chemicals to the cutaneous 
circulation in a highly localized manner. This method uses the electrical potential 
difference between the charge of the drug and the anode or cathode (depending on the 
polarity of the drug) of the iontophoresis system. An iontophoresis system uses a 
chamber to house the drug, laser-Doppler probe centered in the chamber, an electrode to 
supply the charge, and an optional temperature control unit. The electrode orientation 
depends on the polarity of the drug. The electrode matching the charge of the drug is 
attached to the iontophoresis chamber and the other is attached to the skin to create a 
ground. For example, the negative charge from the cathode and a negative charge from a 
drug (sodium nitroprusside) repel each other, and perfuse the drug through the dermal 
layer (85, 106). The chemical must be diluted in a non-conducting solvent so that the 
amount administered is directly proportional to the amount and duration of current 
applied (68, 85, 106). 
Iontophoresis has no systemic effect and only affects a localized area (< 1 cm2) 
allowing for multiple experiments to be performed simultaneously (59). Iontophoresis is 
limited to drug molecules that are polar and that are sufficiently small to perfuse through 
the dermis. Further considerations that have to be accounted for with iontophoresis are 
that if the drug is diluted in an electrolyte solution (Ringer solution), both the drug and 
the electrolyte ions will be perfused into the dermis. When employing this method of 
drug delivery, the amount of drug perfused into the skin varies greatly from person to 
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person as skin conductivity can change (59, 106). Further considerations with 
iontophoresis are the length of experiments as the drugs are applied over a short time 
period (10 – 300 s) but have an ~80 min wash-in period for the effects of the drug to take 
place and for the current-induced hyperemea to subside (104).  
2.3 Skin Blood Flow Response to Local Heating 
The SkBF response to local heating has been well studied (43, 58, 59) over the 
past few decades. This response can be broken down into three sections (see Fig. 1): the 
initial peak, which is characterized by the initial rapid increase in SkBF, the plateau, 
which is the sustained vasodilation response to local heating, and the die away, which is a 
decrease in SkBF following extended periods of time of local heating (3, 58, 59). 
2.3.1 Initial Peak 
The initial response to local heating is characterized by a pronounced and rapid 
increase in SkBF in response to local heating. Full expression of the initial peak requires 
local vasodilators such as nitric oxide (NO) (71, 81), sensory nerves (11, 42, 81, 108), 
and intact sympathetic vasoconstrictor nerves (46, 48, 49).  
NO is produced by nitric oxide synthase (NOS) during the conversion of L-
Arginine to L-Citrulline (20). NOS is inhibited by the non-selective NOS inhibitor, nitro-
L-arginine methyl ester (L-NAME) (69). NOS inhibition prior to rapid (+0.5°C·5 s
-1) 
local heating significantly attenuated the increase in CVC compared to a group with 
functioning NOS by ~17% (81). During NOS inhibition with slow (+0.1°C·60 s-1) local 
heating, the initial peak is shifted to a higher temperature or completely abolished (49). 
These studies suggest that NO is required for full expression of the initial peak; however, 
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it may not be the most important pathway involved in the initial peak, as it is often only 
left shifted to a higher temperature threshold. 
Sensory nerves play a large role in the initial response to local heating (11, 81, 
107). During sensory nerve blockade with a topical anaesthetic (eutectic mixture of local 
anaesthetics; EMLA), the initial peak was reduced in magnitude (11, 42, 81, 108) as well 
as shifted to a higher temperature. Transient receptor potential vanilloid (TRPV) channels 
are activated by heat (98) and are located at the ends of cutaneous sensory nerves (115). 
Inhibiting TRPV-1 receptors with capsazepine inhibited the initial peak by ~50%, 
whereas NOS inhibition only attenuated the initial peak by ~35% (115). 
Sympathetic nerve function is presynaptically abolished with BT, which blocks 
the release of NE and other co-transmitters from sympathetic nerve endings (38, 68). 
Previously, it was thought that sympathetic nerves were only involved with cutaneous 
vasoconstriction, however, it has since been demonstrated that these nerves are required 
for full expression of vasodilation (45, 46, 49). Houghton et al. (49) were the first to 
investigate the role sympathetic nerves played in cutaneous vasodilation and established 
that the initial peak was abolished in response to local heating (46). However, the use of 
BT does not allow the determination if NE or NPY or a combination of the two is 
responsible as BT inhibits the release of all neurotransmitters from sympathetic never 
endings (38). Postsynaptic sympathetic blockade of NE is achieved by blocking α and β 
adrenergic receptors through yohimbine (YOH) and propranolol (PRO), respectively, 
(46). NPY is co-released with NE from sympathetic nerve endings and can be inhibited 
by blocking the Y1 receptor with N2-(diphenylacetyl)-N-([4-hydroxyphenyl] methyl)-D-
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arginine amide (BIBP-3226). Postsynaptic inhibition using YOH and PRO, or BIBP-3226 
shifted the initial peak to a higher temperature or abolished it in response to slow local 
heating (46). During complete postsynaptic sympathetic blockade with YOH, PRO, and 
BIBP-3226 the initial peak was abolished signifying that NE and NPY play an active role 
for full expression of the initial responses to local heating (46). 
Rate of local heating influences the response to local heating. During presynaptic 
sympathetic blockade, BT abolishes the initial peak during slow (+0.1°C·min-1) local 
heating to 42°C. However, the initial peak was preserved with BT, albeit at a less 
magnitude, during rapid (+2°C·min-1) local heating (45, 46). If local heating is performed 
at a rapid rate causing a noxious stimulus (i.e., Rapidly to 44°C), the bi-phasic response 
to local heating is abolished and SkBF proceeds to directly to maximum (11).  
2.3.2 Prolonged Plateau  
The later portion of the biphasic response to local heating is termed the prolonged 
plateau, which is characterized by the stable portion of the response following the initial 
peak and nadir. This plateau is primarily NO-dependent (17, 58, 59, 69, 81), but also 
requires intact sympathetic nerves for full expression (45, 46). Infusion of L-NAME prior 
to- or during-local heating (81) resulted in decreased (Fig. 3A) or attenuated (Fig. 3B) 
vasodilation in response to local heating to 42°C, respectively. Infusing L-NAME during 
local heating rapidly decreased CVC to only 30% greater than baseline (69, 81). Local 
heating to 39°C has been demonstrated to produce a plateau that is almost entirely NO-
dependent (17). When L-NAME is infused prior to and throughout local heating, 
vasodilation is significantly attenuated (46, 69, 81). Since these studies, different 
isoforms of the NOS have become available to study independently (71-73).  
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Figure 3. Role of nitric oxide during prolonged local heating. The top panel (A) shows L-Name 
infused ~45 min into local heating. The bottom panel (B) shows L-NAME infusion 45 min prior 
to and during local heating (81). 
Of the three different isoforms of NOS, endothelial (eNOS) and neuronal (nNOS) 
have been demonstrated to be in high concentrations in human skin (7, 10). Inducible 
NOS is present in skin, albeit in small concentrations compared to e- and n-NOS and only 
reaches levels similar to the others following trauma and inflammation (7, 10). 
Endothelial NOS has been shown to play a critical role in vasodilation in response to 
local heating (71, 73). Nω-amino-L-arginine (LNAA) selectively antagonises the eNOS 
isoform while leaving other NOS isoforms intact (71). Local heating to 41.5°C under 
eNOS inhibition significantly attenuated the increase in CVC, whereas antagonism of 
nNOS had no effect on CVC (71, 73). Importantly, vasodilation occurs when NOS is 
inhibited, indicating mechanisms other than NO are at work. 
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Sensory nerves do not appear to play a role to the absolute magnitude of the 
plateau during local heating (11, 81, 108). TPRV-1 receptors are localized near sensory 
nerve endings and endothelial cells (115). TPRV-1 receptor inhibition with capsazepine 
significantly attenuated plateau portion of the SkBF response to local heating (115).  
EDHFs are a group of factors that are capable of causing cutaneous vasodilation 
by hyperpolarizing vascular smooth muscle through stimulating calcium-activating 
potassium channels (8, 59). EDHFs can be non-selectively inhibited via calcium-
activating potassium channel antagonist tetrathylammonium, or certain factors can be 
selectively inhibited with other drugs. Tetrathylammonium reduces the plateau 
marginally from control, but when EDHFs and NOS are inhibited together, nearly all 
hyperemic response to local heating was abolished (Fig. 4, (8)). Exocyeicosatrienoic acid 
is a type of EDHFs that is selectively inhibited using a cytochrome P450 inhibitor, 
sulfaphenazole. Exocyeicosatrienoic acid inhibition during local heating slightly 
attenuates vasodilation demonstrating that they were responsible for about 50% of EDHF 
mediated vasodilation (8). 
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Figure 4. Representative tracing from non-selective NOS and EDHF inhibition in response to 
local heating to 44°C. EDHF inhibition affected nadir and the plateau. The combination of EDHF 
and NOS inhibition allowed for a slight initial peak and almost inhibited the plateau in response 
to local heating (8). 
Similar to the initial peak, the plateau during prolonged heating requires intact 
sympathetic nerves for full vasodilation. Presynaptic blockade of sympathetic nerves with 
BT led to an attenuated prolonged vasodilation response during slow and rapid heating 
protocols (45). Postsynaptic blockade of either NE or NPY attenuated maximal SkBF 
response to local heating (46). When YOH, PRO and BIBP-3226 are administered at the 
same time there were no exacerbated effects on peak vasodilation, which supports the 
notion that these systems work in conjunction with each other as they are both released 
from sympathetic nerve endings (46). 
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2.3.3 Die Away 
Following prolonged application of local heating to non-glabrous skin, a notable 
decrease in SkBF occurs (Fig. 1; (3, 45, 59)). Die away was initially observed by Barcroft 
and Edholm (3) using forearm submersion into water baths, and observed that it only 
occurs between 37 –  42.5°C. Recently, it has been found that this decrease in blood flow 
is sympathetically mediated (43, 45). Hodges et al. (45) found that when sympathetic 
function was presynaptically blocked with BT, the decreases in CVC did not occur.  
2.4 Skin Blood Flow Response to Whole Body Heating 
There are two primary methods researchers use to study the reflexive SkBF 
control, specifically an active and a passive model. Active models have participants 
exercise to induce an elevation in T̅sk, and if exercise is long and intense enough, an 
increase in Tc. Passive models involve participants either entering a water bath, warm air, 
or donning a liquid conditioning garment (LCG) to increase T̅sk and if the stimulus is 
applied for a prolonged period of time, an increased Tc. Two paths of heat loss occur, 
sudomotor activity (sweating) and cutaneous vasodilation. This section will focus on the 
reflexive cutaneous vasodilation response to whole-body heating.   
2.4.1 Active Heating 
During exercise, heat is generated internally by exercising muscles and a 
redistribution of blood occurs in an attempt to dissipate the heat produced (91). A 
competition for blood occurs with prolonged exercise as a result of the demand for blood 
to the working muscles, the cutaneous circulation to dissipate heat produced, and 
decreased plasma volume via sweating (36, 55). Blood is redistributed away from the 
splanchnic (91, 92) and cutaneous circulation (36, 55, 67) with the onset of exercise to 
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increase blood flow to areas of active skeletal muscle. An increase in sympathetic 
outflow at the onset of exercise is responsible for the vasoconstriction (67, 91, 92). 
Kellogg et al. (67) infused BT prior to exercise and abolished exercise induced cutaneous 
vasoconstriction. 
During exercise, the Tc threshold that vasodilation occurs at is shifted to higher 
temperatures (55, 65-67, 74, 86). This shift is not due to sympathetic withdrawal, as 
inhibition of the sympathetic nervous system using BT did not have an effect on this 
temperature threshold (65-67, 86). The increase in Tc temperature threshold that 
vasodilation occurs at is increased following exercise (74) as well making 
thermoregulation increasingly difficult due to a reduction in convective heat loss abilities. 
2.4.2 Passive Heating 
A passive heating model involves creating a hot environment that heats the body 
from the outside. In response to a warm stimulus on the skin, there is increased blood 
flow to the cutaneous circulation, which heats the blood and returns it to the core heating 
both T̅sk and Tc in a feed-forward manner. More blood flow is sent to the cutaneous 
circulation as the body heats to attempt to limit heat gain, which facilitates increases to 
Tc. A popular method to induce passive heat stress is through the use of a LCG (34, 83, 
109). These garments circulate hot water (~50°C) to raise T̅sk to ~38.5°C and Tc by a 
desired amount. Sympathetic withdrawal is responsible for the initial portion of 
vasodilation at rest (27, 32, 37, 86, 89). Pretreating areas with BT failed to initially 
increase SkBF in response to whole-body heating, whereas control sites did increase 
SkBF (65). Vasodilation due to sympathetic withdrawal is only responsible for 5 – 15% 
of vasodilation and the remaining 85 – 95% is due to active vasodilation (12, 22, 56). 
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Active vasodilation from passive heat stress is mediated through cholinergic 
nerves (59, 70, 100). Botulinum toxin A can be injected to presynaptically inhibit the 
release of acetylcholine and associated neurotransmitters to elucidate the role of 
cholinergic nerves involvement in active vasodilation (70). An intradermal injection of 
botulinum toxin abolished active vasodilation in response to whole-body heating (Fig. 5, 
(70)). Acetylcholine released from cholinergic nerves play an important role in the early 
response to heat stress as inhibition facilitated an earlier body temperature threshold for 
vasodilation to occur, however, it did not have an effect once SkBF began to notably 
increase (100). 
 
Figure 5. Effect of botulinum toxin injection on vasoconstriction (cold stress), reflexive 
vasodilation (whole-body heating) and local vasodilation (local heating) response compared to 
control (70). 
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Nitric oxide plays an important role facilitating vasodilation in response to whole-
body heating (64, 72, 73, 81, 99). NOS inhibition during passive heat stress between 0.6 
– 1.0°C significantly attenuated the SkBF response compared to control (64). Infusing 7-
nitroindazole (72) or Nω-propyl-L-arginine (NPLA) (73) selectively inhibits the nNOS 
isoform allowing for its contribution to reflexive vasodilation to be assessed. Reflexive 
vasodilation was augmented during nNOS inhibition (72), but was not affected during 
eNOS inhibition (71, 73). NOS activity is required for full expression of vasodilation, as 
it is not completely abolished during NOS inhibition suggesting there are other 
mechanisms at play. 
Sensory nerves have been exposed to play a role in the sensitivity of reflexive 
vasodilation, as EMLA application delayed the onset of it (113). Inhibition of sensory 
nerves alone do not affect CVC during passive heating, but when sensory nerve and NOS 
were inhibited, CVC was significantly lower than NOS inhibition alone (113). TPRV-1 
receptors are responsible for a small portion of the sensitivity and absolute magnitude of 
the reflexive cutaneous vasodilation response (114).  
Prostaglandins are involved in many physiological roles throughout the human 
body, one of which is to facilitate vasodilation. Cyclooxygenase-1 and -2 are important 
enzymes in the formation of prostanoids, which can be inhibited using ketolorac (KETO). 
The vasodilatory plateau reached during cyclooxygenase inhibition was attenuated 
compared to control (Fig 6. (79)). A further reduction in CVC occurred with combined 
inhibition of NOS and prostanoids suggests that these two pathways are independent of 
each other (79).  
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Figure 6. Vasodilation associated with whole-body heating during NOS (L-NAME), 
Cyclooxygenase-1 and -2 (KETO), and no (control) inhibition (79). 
2.5 Methods to Measure Skin Blood Flow 
2.5.1 Venous Occlusion Plethysmography  
Venous occlusion plethysmography involves inflating a blood pressure cuff to 
less than arterial diastolic pressures but greater than venous pressure (59). Alternatively, a 
method is to inflate a distal cuff to suprasystolic pressures (i.e., 200 mm Hg) and a 
proximal occlusion cuff inflated to just under diastolic pressure to allow blood flow into 
the limb (19, 97). This allows blood to flow into the limb while trapping blood distal to 
the cuff; therefore the rate of volume increase of the limb directly proportional to the 
amount of blood flowing into it. A strain gauge is placed on the midpoint of the forearm 
which measures the amount of volume increase occurs during occlusion (97). An 
advantage of using plethysomograpy is that the values can be expressed as absolute flow 
value (ml·100 g-1) (59, 97). 
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Venous occlusion plethysmography is limited to limbs that are large enough for a 
blood pressure cuff and a strain gauge placed distal to the cuff. Areas that 
plethysmography can be used are the forearm, calf, hand, and foot (59). Plethysmography 
is not limited to the measurement of SkBF but also underlying muscle blood flow as the 
gauge measures changes in total limb volume (19, 57). Further difficulties with 
plethysmography are that during periods of rapid increases in SkBF, such as rapid whole-
body- or local-heating or cooling, errors can occur when determining SkBF from total 
forearm blood flow (97). This is partly due to the measurement schedule of 
plethysmography only allowing for two to four times per minute, and is therefore unable 
to capture rapid changes to cutaneous circulation (105). Since plethysmography is not a 
continuous digital signal, further analysis of the signal is not possible using this method. 
2.5.2 Laser-Doppler Flowmetry 
Laser-Doppler flowmetry (LDF) involves emitting laser light into tissue delivered 
from a fibre optic probe. Light is then scattered into the tissue being studied and partly 
absorbed. A LDF probe is primarily composed of a sender and a receiver. The sender 
delivers the laser light into the skin and the receiver picks up light that is reflected back. 
The beam of light being emitted from the sender has a wavelength of 780 nm. If the light 
comes in contact with a static object (i.e., arterial wall), the light being returned to the 
receiver will be the same wavelength as it was from the sender. When light hits a moving 
object (i.e., red blood cell) it undergoes a Doppler shift (change in wavelength) (87) 
before being picked up by the receiver. The amount of Doppler shift that the light 
undergoes depends on the number of cells and the velocity of the cells that the light 
makes contact with (87). The Doppler shifted light is returned to the receiver, converted 
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into an electrical signal, and returned as arbitrary ‘perfusion units’. Importantly, perfusion 
units are related to red blood cell flux, and not flow, as vessel diameter is not attainable 
with LDF measurements. Red blood cell flux is the product of the concentration of 
moving blood cells and their respective velocity.  
Criticisms of LDF measurements are that there is a lack of consistency for the 
depth of measurement and its inability to measure blood flow (87). Depth of 
measurement depends on many factors including the concentration of capillaries, 
pigmentation of skin, oxygenation of blood, etc. However, the depth of measurement on 
the skin is approximately 0.5 – 1.0 mm, whereas when measuring other tissue such as the 
liver or the spleen, which have a much higher density of cells than skin, will have a much 
smaller depth of measurement. Measurement depth of 0.5 – 1.0 mm is due to the 
separation of probes being 0.25 mm, and a wavelength of 780 nm (87). Regardless of the 
fact there is no true depth measurement, Saumet et al. (96) demonstrated that LDF is not 
affected by underlying muscle blood flow during exercise and is an accurate 
representation of SkBF. Since red blood cell flux and not flow is reported using LDF, 
data is commonly normalized to maximal values by heating the site of measurement to 
44°C and maintained until values stabilize (42, 108, 110). 
There are many advantages to using LDF to assess SkBF. It is capable of 
capturing real time changes to the skin microvascular circulation. This is advantageous 
over plesythmography because LDF is able to capture abrupt changes to SkBF following 
temperature or drug manipulations. Another advantage of LDF is the non-invasive nature 
of the technique, whereas former methods involved injecting radioactive substances 
(xenon, radioactive microspheres) into the circulation (87), or having participants wear 
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multiple blood pressure cuffs and strain gauges. Its versatility compared to 
plethysmography is advantageous as laser-Doppler probes can be placed almost 
anywhere, from the fingertips (30) to the forehead (4), and investigate differences 
between glabrous and nonglabrous skin. This is beneficial when assessing SkBF during 
cold exposure to the extremities, and also looking at clinical populations and the effect of 
the disease on SkBF and to see if they are at an increased risk of circulatory diseases. 
Perhaps one of the strongest advantages of LDF is that the signal can be decomposed and 
allows insight into the mechanisms influencing SkBF without introducing drugs or 
needles into the cutaneous circulation. 
2.4.2.1 Wavelet Analysis 
Wavelet analysis involves decomposing the LDF signal into frequency and time 
components, offering high resolution for both. Unlike sinusoids involved with the fast 
Fourier Transform, wavelet transforms have discrete beginnings and endings that are 
translocated along the signal allowing for both high time and frequency resolution (1, 6, 
50, 51, 103) High frequencies take a very short period of time to complete their period 
and allow for good time and frequency resolution, however, low frequency components 
take longer to complete their period, requiring longer time windows that create poor time 
resolution. Wavelet analysis has been shown to demonstrate accurate time and frequency 
resolution at both low and high frequencies (1, 6, 50, 51, 103). 
The fast Fourier Transform involves using sinusoids infinitely long to recreate a 
signal that allows for high frequency resolution, however does not allow for detection of 
when an event occurred in time (35). The short-time Fourier Transform utilizes shorter 
time windows that allows for better time resolution, however does not facilitate good low 
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frequency resolution (102). The physiological control mechanisms of SkBF are 
composed of nonstationary components and are very low frequencies (as low as 0.005 
Hz), which make the short-time- and the fast-Fourier Transform inadequate (6, 101, 103).  
Signals can be reconstructed and analyzed using a combination of sine waves of 
varying frequencies and amplitudes. Decomposing the laser Doppler signal using wavelet 
analysis allows for the investigation of the physiological control mechanisms of SkBF. 
The frequency domain of interest for blood flow dynamics is between 0.005 – 2.0 Hz (6, 
50, 51, 76, 103). The frequency of the heart rate is the upper frequency limit (2 Hz) as it 
is the fastest physiological rhythm associated with vasomotion (103). Vasomotion can be 
broken up into six frequency domains that correspond to physiological functions (6, 35, 
75, 76, 103). The frequency band associated with endothelial function can be further 
broken down into a NO-independent and a NO-dependent frequency range (51, 75, 76). 
The highest peak frequency of around 1 Hz is associated with an individual’s heart rate. 
This peak can change based on fitness level, with fit individuals demonstrating a peak 
close to 0.6 Hz, whereas the peak in individuals with a cardiovascular impairment was at 
1.6 Hz (103). The peak around 0.27 Hz is related to respiratory activity. The peak around 
0.10 Hz is related to myogenic activity, which is responsible for the oscillations observed 
in vasomotion and caused from changes in intra-arterial pressures (6). The peak around 
0.04 Hz is related to neurogenic activity. The lowest peak around 0.01 Hz is associated 
with local metabolic activity, such as NO and prostaglandins (35).  
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Table 2. Frequency and their corresponding physiological function of vasomotion. aThe 
endothelial band broken up into an endothelial-independent and -dependent aspect (76). 
Frequency Band (Hz) 
Corresponding Physiological 
Function 
0.0095 – 0.02 Endothelial 
0.005 – 0.01 NO-independenta 
0.01 – 0.02 NO-dependenta 
0.02 – 0.05 Neurogenic 
0.05 – 0.15 Myogenic 
0.15 – 0.4 Respiratory 
0.4 – 2.0 Cardiac 
 
What makes wavelet analysis appealing is that much of the information that can 
be obtained was previously only available through pharmacological interventions. For 
example, in order to assess sympathetic activity with drugs, researchers would have to 
apply BT through iontophoresis (68) or microdialysis (44) to presynaptically abolish the 
sympathetic control of SkBF and compare the differences between treated and untreated 
sites. The difference between the treated and the untreated site would be attributed to 
sympathetic regulation of SkBF. Analyzing the frequency band associated with 
neurogenic activity can assess the sympathetic contribution to SkBF during thermal, 
orthostatic, exercise, etc., stress.  
Although there are many different types of wavelets that can be used including 
the Dauchechies, Haar, lognorm, and Morlet wavelet (1, 50, 51), the Morlet wavelet is 
the most popular choice when studying blood flow dynamics (6, 54, 103). The Morlet 
wavelet is a Gaussian (normal distribution) function that has been altered with a sine 
wave (6) and is used most commonly in blood flow dynamic research as it offers good 
time and frequency resolution following the uncertainty principal (6, 50, 51).   
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2.6 Thermal Balance 
Alterations to SkBF are one of the human body’s primary defence mechanisms 
against thermoregulatory challenges. Internal heat production comes from metabolic 
energy pathways and contracting muscles. External heat loss or gain is a result from 
convective, conductive, radiative and evaporative sources. Internal heat production and 
external heat loss or gain is depicted in the heat balance equation:  
?̇? =  ?̇?  ± ?̇?  ± ?̇?  ± ?̇?  ± ?̇? − ?̇?  
?̇? is heat storage within the body. When this value is positive, it represents a gain 
in heat leading to hyperthermia. A negative value indicates a net heat loss by the body, 
which can lead to hypothermia. ?̇? is metabolic heat production, ?̇? is external work 
performed, ?̇?, ?̇?, ?̇?, and ?̇? are radiative, convective, conductive and evaporative heat 
losses or gains, respectively (14, 80). 
In cold stress, thermal homeostasis is maintained by decreasing the amount of 
heat lost to the environment through evaporative, conductive and convective pathways 
through vasoconstriction and piloerection (111). In cases of heat stress, SkBF increases in 
an attempt to maintain thermal homeostasis by increasing the amount of heat dissipated 
to the environment by evaporative, conductive and convective heat loss (111). 
A redistribution of blood occurs with heat stress (90, 91). Heat applied to the skin 
causes an increase in blood flow to the extremities in an attempt to decrease heat gain. 
With heat stress, cutaneous vasodilation occurs and there is an increased blood flow to 
the extremities (especially the hands and feet) to act as heat exchangers (9). The increase 
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in cutaneous blood flow is mediated by vasoconstriction and a decrease blood flow to the 
splanchnic region (Fig. 7, (91)).  
 
Figure 7. Redistribution of blood in a cool and heat stressed individual. The dark areas represent 
high amounts of blood volume (Adapted from (90)). Note the increased shaded areas representing 
more blood flow at the extremities when the body is hot. 
2.6.1 Core Temperature 
Previous work has largely investigated the mechanisms behind SkBF in response 
to local or whole body temperature manipulations (43, 58, 59), with changes to either T̅sk 
or Tc, yet only a few have successfully isolated the afferent inputs (33, 57, 97, 105, 116, 
117). Previous work (57, 105, 116, 117) has shown that increasing local arm temperature 
surges SkBF during normothermia, and during passive heating reflexive vasodilation 
occurs in the control arm from whole-body heat stress even when it is maintained in a 
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thermoneutral background. They concluded that passive heat stress to ∆+1°C above 
baseline temperature induced maximal vasodilation (105), and that reflexive control of 
SkBF is more influential than local control of SkBF (57, 116, 117). Importantly, no local 
temperature manipulations were performed during hyperthermia to determine if the 
interaction between local- and reflexive-control mechanisms of SkBF 
Core temperature plays a large role in many physiological adaptations. Frank et 
al. (33) studied the isolated effects of skin temperature and core temperature on SkBF, 
metabolic heat production and circulating catecholamines by manipulating T̅sk via the use 
of two temperature controlled mattresses, and rapidly cooled Tc by 1.5°C by injecting a 
large quantity of 4°C saline. Through multiple regression analysis, it was determined that 
Tc influenced SkBF in glabrous skin was 3.1 times more than T̅sk increased metabolic 
heat production 2- and 3-fold for neutral (34°C) and cold (30°C) skin, respectively, and 
increased circulating epinephrine and NE 1.8 and 3.0 times more than T̅sk (33). Contrary 
to SkBF, CIVD research has had considerable attention in the past decade concerning the 
CIVD response in relationship to Tc and T̅sk (29-31). Importantly, CIVD occurs in areas 
of glabrous, non-hairy skin that is only innervated by sympathetic vasoconstrictor nerves, 
whereas sympathetic vasoconstrictor and cholinergic nerves (15, 23, 59) innervate SkBF 
in nonglabrous, hairy, skin. CIVD originates from arterio-venous anastomoses (AVAs) 
that are deep within the tissue and only regulated by sympathetic vasoconstrictor nerves 
(15, 23).  
Core temperature plays a critical role for CIVD occurrences. After the initial 
decrease in T̅sk due to cold exposure, a CIVD occurrence is denoted by an increase in 
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finger temperature. There is discrepancy of a tangible definition of how much of an 
increase in finger temperature qualifies as a CIVD occurrence, however a range of Δ +0.5 
to +4°C is common throughout the literature (15, 16) measured by thermistors placed on 
the fingertip or toe. Previous work has shown that CIVD occurs more when body 
temperature is elevated (24, 29-31). CIVD events occurred most often when immersing 
the hand in cold water (24, 29), or being exposed to cold air (30, 31), and when Tc was 
above baseline. Recently it was shown that most CIVD events occur when mean body 
temperature (a combination of T̅sk and Tc) is above baseline levels (29-31). Utilizing an 
A-B-A-B (warm-cold-warm-cold) protocol, Flouris and Cheung (29) demonstrated that 
CIVD occurred when Tc was above baseline levels but body heat content was negative. 
However, when Tc fell below baseline, CIVD did not occur and blood flow to the finger 
was almost non-existent (29). During another A-B-A-B protocol, these authors concluded 
that finger blood flow was a function of the rate of change to mean body temperature and 
heat storage (30).  
2.6.2 Skin Temperature  
Humans have an innate ability to adapt behaviourally and physiologically. 
Behavioural adaptations appear to be driven equally by both T̅sk and Tc input (33), which 
plays an important role in human behavioural adaptation to alterations in temperature. 
This study demonstrated that physiological adaptations are largely related to Tc whereas 
behavioural changes are more equally dependent on Tc and T̅sk. 
Skin temperature plays an important role in protecting Tc from external cold 
stimulus. Lowering whole body skin temperatures increase the internal temperature 
threshold for active vasodilation to occur (86), in order to maintain current Tc. Skin 
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temperature plays an important role in reflexive vasoconstriction in an attempt to 
maintain Tc. Savage and Brengelmann (97) rapidly reduced T̅sk by 2°C with one forearm 
exposed to temperature alterations, and one forearm bare to the surrounding room 
environment. Rapid reduction in mean body skin temperature of 2°C resulted in net 
vasoconstriction in both the exposed and non-exposed forearm in an attempt to limit 
convective heat loss (97) leading to an increase in Tc, suggesting that reflexive 
vasoconstriction was able to protect core body temperature. 
2.6.3 Skin and Core Temperature Interaction 
Physiological and behavioural adaptations that humans make are modulated by 
both central and peripheral inputs, however much of the previous literature has only 
studied the effects one of the other (46, 49, 58, 73). From these studies, many 
mechanisms controlling SkBF in response to local and whole body temperature 
manipulations (43, 58, 59), as well as exercise (55), are known. However, the isolation of 
T̅sk and Tc has not been well studied (57). Clearly, Tc does play a role in SkBF regulation 
as demonstrated by a collection of studies looking at thermal balance and CIVD 
occurrences (29-31), however it is still unclear whether Tc or local T̅sk is what regulates 
SkBF, and what are the mechanisms behind this.  
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CHAPTER THREE: OBJECTIVES AND HYPOTHESIS 
3.1 Objectives 
 The objectives of this study are to: 
1. Determine if Tre or Tloc is the driving force of forearm SkBF by comparing an arm 
maintained at thermoneutral (33°C) and the other’s Tloc being manipulated in an 
A-B-A-B fashion between neutral (A; 33°C) and hot (B; 38.5°C) during normo- 
and hyper-thermia (∆Tre +1.1°C). 
2. Perform spectral analysis on the laser-Doppler signal to determine the 
mechanisms behind SkBF control during normo- and hyper-thermia.  
3.2 Hypotheses 
 The specific hypotheses of this study are: 
1. Tloc will be the driving force behind forearm SkBF during normothermia. 
2. Forearm SkBF will not respond to Tloc changes during hyperthermia.  
3. Reflexive vasodilation during hyperthermia will increase skin blood flow to the 
control arm. 
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CHAPTER FOUR: METHODS 
4.1 Sample Size Estimation and Participant Characteristics 
The study was approved by the Bioscience Research Ethics Board of Brock 
University (BREB #13-283) and conformed to the standards set by the Declaration of 
Helsinki. All participants were informed of the experimental protocol and the associated 
risks prior to participating in the experiment. Verbal and written consent was obtained 
from each participant. 
Cohen (18) says a ratio of 4:1 should be made between Type II and Type I error. 
Therefore, the ratio adopted for this study was 4:1 with β = 0.20 and α = .05, resulting in 
a power (1 – β) equal to 0.80. Pilot data and a priori power analysis demonstrated that 8 
participants would be required for such a study.  
To accommodate for potential participant dropout or technical issues, 10 healthy 
and active individuals (7 males and 3 females) were recruited for the experiment with no 
diagnosed metabolic or cardiovascular diseases; participants also did not smoke or take 
any prescribed medication other than oral contraceptives. In order to control for sex 
differences in thermoregulation, females were tested within the first 10 days of the onset 
of self-reported menses, or during the placebo/no pill phase if taking oral contraceptives, 
as no sex-related difference in maximal SkBF are observed during this phase from 
passive heating (34). The mean (± SD) for age, height, mass, body fat percentage, and 
peak oxygen uptake (?̇?O2peak) of all participants was 23.1 ± 1.8 years, 173.3 ± 7.4 cm, 
65.3 ± 7.9 kg, 13.8 ± 5.8 %, and 56.4 ± 5.2 ml·kg-1·min-1, respectively. 
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4.2 Experimental Design 
All participants completed a familiarization and an experimental session. 
Participants were instructed to avoid strenuous exercise and caffeine 12 h prior, and 
alcohol consumption 24 h prior to the experimental session. Additionally, participants 
were advised to have a light meal 1 to 2 h before the experimental session, and instructed 
to drink water ad libitum. During the familiarization session, height, weight, body fat 
percentage (%), and V̇O2peak were determined. Height and weight were measured with 
standard laboratory equipment. Body fat percentage was calculated through a 7-site 
skinfold measurement (52, 53) with manual calipers (Harpenden, Bay International, West 
Sussex, UK). ?̇?O2peak was determined through indirect calorimetry (Gas Analyzer, 
ADInstruments; Labview software) during a progressive running test until volitional 
exhaustion on a treadmill (Trackmaster TMX22, Full Vision Inc., Newton, KS, USA). 
  
 
35 
 
Figure 8. The left panel is the forearm instrumented. I is the laser-Doppler probe, II-IV are 
proximal (II), middle (III), and distal (IV) thermocouples used to calculate mean forearm 
temperature. The right panel is the forearm submerged and positioned for the duration of the 
experiment. 
Participants arrived at the laboratory (~22°C, ~35% relative humidity) between 
0800 – 1200 h for the experimental session. Euhydration was confirmed using a 
refractometer (PAL-10S, Atago, USA) and defined as a urine specific gravity (USG) ≤ 
1.020. If the participant was hypohydrated (USG > 1.020), 0.5 L of water was given and 
USG was reassessed after 30 min. If participants were still hypohydrated, testing was 
I 
I
I
III 
IV 
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rescheduled. If euhydration was confirmed, participants were instructed to self-insert a 
rectal thermistor (Mon-A-Therm Core, Mallinkrodt Medical, St. Louis, MO, USA) 15 cm 
beyond the anal sphincter to assess rectal temperature (Tre). 
Thermocouples (PVC-T-24-190, Omega Environmental Inc., Laval, QC, CAN) 
were taped (TransporeTM, 3M, St. Paul, MIN, USA) to the chest, thigh, upper arm and 
calf to calculate mean skin temperature (T̅sk), calculated using the weighted average of 
the four thermocouples (88): 
T̅sk = 0.3(thigh) + 0.3(chest) + 0.2(calf) + 0.2(arm). 
Participants then dressed in a three-piece liquid conditioning garment (LCG; BCS 
4 Cooling System, Allen Vanguard, Ottawa, ON, CAN), consisting of 1/8” diameter 
Tygon tubing sewn over stretchable hood, torso, arms, and legs; the face, forearms, 
hands, and feet were left uncovered. Males wore only shorts and females wore shorts and 
a sports bra under the LCG to expose a large amount of skin to facilitate heat transfer to 
the body. To eliminate evaporative heat loss, a polyvinyl rain suit was worn over the 
LCG. Water temperature of the LCG was manipulated by adding hot or cold water, 
maintained at a constant temperature by a temperature controller (Model 5202, 
Polyscience, Niles, IL, USA) and pumped (MED-ENG, Pembroke, CAN) at a flow rate 
of ~1.5 L·min-1. 
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Figure 9. Positioning of participant for the duration of the experiment. 
The dorsal surface of each forearm was equipped with three thermocouples 
(Omega Environmental Inc.) located on the proximal, middle, and distal portion to 
calculate mean forearm temperature (Fig. 8). Red blood cell flux was assessed with laser-
Doppler flowmetry (5010 LDPM, Perimed, Järfälla, Sweden) and used to provide an 
index of SkBF (61, 96). A combined laser-Doppler flux (LDF) and skin heater probe 
(Probe 451, Perimed) was taped (PF 105-3, Perimed and TransporeTM, 3M) to the dorsal 
surface of each forearm. Thermocouples and LDF probes were held in place with nylon 
wrapping (BurnNet, Glenwood Laboratories, Oakville, ON, CAN). Participants sat semi-
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recumbent in a Kore-Kooler® Rehab Chair (DQE, Fishers, IN, USA) with feet elevated 
to the height of their pelvis (Fig. 9). Each hand and forearm was immersed in individually 
temperature controlled water baths (Glad ForceFlex® Contractor Bags, Clorox Company 
of Canada, Brampton, ON, CAN) insulated with solar blanket for the duration of the 
experiment. During the ‘B’ manipulations (see 4.3 Experimental Protocol), the 
experimental arm was kept warm with a heated blanket (Life Brand Heating Pad, 
Brampton, ON, CAN). 
4.3 Experimental Protocol 
See Figure 10 for a schematic of the protocol and Table 3 for temperatures 
attained during each block of the protocol. The protocol began by circulating water 
through the LCG to obtain a T̅sk of ~33°C, and forearm baths were adjusted to make both 
forearm temperatures ~33°C. Once LDF values were stable, 5 min of baseline (A1) data 
were collected. Control forearm temperature (T̅con) was maintained at ~33°C for the 
duration of the normo- and hyper-thermic assessment. Following A1 measurements, 
experimental forearm temperature (T̅exp) was rapidly increased to 38.5°C (B1) and 
maintained for 5 min. A second ‘A’ measurement occurred by returning T̅exp to 33°C 
(A2) for 5 min. The final ‘B’ measurement (B2) ensued by increasing T̅exp to 38.5°C for 5 
min. Following the final ‘B’ measurement, participants were passively heated by 
increasing the water temperature circulating through the LCG from ~32°C to ~49.5°C to 
elicit a 1.1°C rise in Tre above baseline values (the temperature from the last 60 seconds 
of normothermic measurements).  
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Table 3. Rectal (Tre), skin (T̅sk), control (T̅con), and experimental (T̅exp) arm temperatures (°C) 
during each manipulation. Each ‘A’ and ‘B’ manipulation was approximately 5 min. Tre displayed 
is hypothetical data as each participant began at different temperatures. The light grey area is 
when participants were passively heated to increase Tre, and the dark grey area is when local skin 
heating occurred at the site of blood flux measurements was performed to obtain maximal flux 
values. 
 A1 B1 A2 B2 
Whole 
Body 
Passive 
Heating 
B1 A1 B2 A2 
Local 
Heat 
to 
44°C 
T̅con  33 33 33 33 33 33 33 33 
T̅exp 33 38.5 33 38.5 38.5 33 38.5 33 
T̅sk 33 33 33 33 38.5 38.5 38.5 38.5 
Tre 37.1 37.1 37.1 37.1 38.2 38.2 38.2 38.2 
 
After Tre increased 1.1°C, 5 min of hyperthermic baseline data collection was 
performed. Again, T̅con was maintained at 33°C throughout and T̅exp was manipulated in 5 
min blocks. Measurements began with T̅exp at 38.5°C (B1) for 5 min before being 
decreased to 33°C (A1). After 5 min, T̅exp was returned to 38.5°C (B2). T̅exp was again 
decreased to 33°C (A2) after 5 min. Following the fourth temperature manipulation, 
maximal CVC was attained by increasing both LDF probes’ temperature from 33°C to 
44°C, at a rate of 3°C·min-1 until 42°C, and then at a rate of 1°C·min-1 until 44°C. Probe 
temperature was maintained at 44°C until a stable LDF plateau had been reached 
representing physiological maximal flux (42, 108, 110), at which point the experiment 
was completed. During the maximal flux portion, T̅exp and T̅con were ~ 34°C. 
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4.3.2 Physiological Variables 
Heart rate (HR) was continuously obtained from R-R intervals using a 3-lead 
electrocardiogram (Bio Amp, ADInstruments, Colorado Springs CO, USA) and 
calculated using Lab Chart (version 8, ADInstruments). Blood pressure was recorded at 
the left ankle (5) before and after the normo- and hyper-thermic assessment using a 
manual sphygmomanometer. The ankle was used as a substitute for the arm as we did not 
want to occlude blood flow to the forearm and cause a reactive hyperemic response (77) 
at the site of SkBF measurement. Mean arterial pressure (MAP) was calculated using the 
following equation for normo- and hyper-thermia: 
MAP = (0.66 . Diastolic Blood Pressure) + (0.33 . Systolic Blood Pressure) 
 
4.4 Data Processing 
Laser-Doppler (SkBF and Probe temperature) and temperature (Tre, T̅sk, T̅exp, and 
T̅con) data were collected at 40 Hz and ECG at 1 kHz (PowerLab, ADInstruments), 
respectively, and stored on a personal computer to be analyzed and processed offline 
using Lab Chart (version 8, ADInstruments). Laser-Doppler data had a time-constant of 
0.1 s and were used to calculate CVC by dividing LDF (PU) by calculated MAP (mmHg) 
for both normo- and hyper-thermia.  
Data were then normalized to maximum CVC and expressed as percentage of 
maximum CVC (CVC%max). Data from the ‘A’ manipulations were obtained from the 
lowest 30 s of LDF data, while data from the ‘B’ manipulations were taken as the highest 
30 s peak of LDF. Maximal flux was obtained from the highest 5 min stable plateau. 
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LDF data were prepared for wavelet analysis with a custom written MATLAB® 
(The Mathworks, Inc., Natick, MA, USA) code. Data were detrended using a third-order 
polynomial, and bandpassed filtered between 0.0045 and 2.5 Hz. 
4.5 Statistical Analysis 
Data were normally distributed as assessed by Q-Q plots, skewness and kurtosis 
measures. Normality was defined as skewness less than ± 3 and kurtosis less than ± 9. 
Results are presented in mean ± S.E.M. Data collected were analyzed with a 2-way (core 
x time) repeated measures analysis of variance (ANOVA) for the control and 
experimental arm. Bonferroni post-hoc corrections were performed to test multiple 
comparisons. Paired samples t-tests were performed to test significant main effects at 
specific time points. Orthogonal polynomials were used to compare trends (linear, 
quadratic, and cubic) in the means of CVC, LDF, T̅exp, Tre and T̅sk during normo- 
compared with hyper-thermia. 
Skin vasomotion data were assessed with spectral analysis of the LDF signal. 
Paired samples t-tests were performed on seven frequency bands were analyzed for the 
control arm between normothermia and hyperthermia: 0.0095 – 0.02 Hz, 0.005 – 0.01 
Hz, 0.01 – 0.02 Hz, 0.02 – 0.05 Hz, 0.05 – 0.15 Hz, 0.15 – 0.4 Hz, 0.4 – 2.0 Hz. Paired-
samples t-tests were performed between each frequency domain between normo- and 
hyper-thermia. The frequency spectrum was analyzed in five intervals for the 
experimental arm: 0.0095 – 0.02 Hz, 0.02 – 0.05 Hz, 0.05 – 0.15 Hz, 0.15 – 0.4 Hz, 0.4 – 
2.0 Hz. Two-way (core x time) repeated measures ANOVAs were performed of each 
frequency interval between the four time points (A1, B1, A2, and B2). Bonferroni post-
hoc corrections were performed to test multiple comparisons. Paired-samples t-tests were 
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performed between each frequency domain between normo- and hyper-thermia for each 
Tloc manipulation. 
All statistical analyses were performed with SPSS (version 20, SPSS, Chicago, 
IL, USA). Complex interactions were explored using orthogonal polynomials to evaluate 
trends within the data. The level of significance was set to p < 0.05, with exception to the 
post-hoc testing as a Bonferroni adjustment was applied. 
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CHAPTER FIVE: RESULTS 
5.1 Thermal Manipulations 
The thermal protocol was successful in eliciting the desired manipulations of local 
and whole-body temperature (Fig. 10; bottom panel). During normothermia, Tre and T̅sk 
were 37.0 ± 0.1°C and 33.5 ± 0.1°C, respectively. After the completion of normothermia, 
participants were passively heated for 95 ± 7 min to achieve a ~1.0 ± 0.1°C rise in Tre. 
Hyperthermia measures were then performed with Tre and T̅sk at 38.1 ± 0.1°C and 38.4 ± 
0.3°C, respectively (both p < 0.001 vs. normothermia).  
Control arm temperature (T̅con) decreased (33.3 ± 0.1°C) throughout 
normothermia (p = 0.010). See Table 4 for detailed T̅con and experimental arm 
temperature (T̅exp) throughout the measurement periods. T̅exp was significantly higher 
during the ‘B’ manipulations compared to the ‘A’ manipulations. Time to increase T̅exp 
from the ‘A’ to ‘B’ manipulations ranged from 30 – 160 s, whereas to decrease from the 
‘B’ to ‘A’ manipulations took between 46 – 156 s, with each phase lasting between 270 – 
360 s. 
HR and MAP increased from 62 ± 3 beats·min-1 and 86 ± 1 mm Hg during 
normothermia, to 103 ± 5 beats·min-1 and 94 ± 2 mm Hg (both p < 0.001 vs. 
normothermia) during hyperthermia.  
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Table 4. Temperature of the control (T̅con) and experimental (T̅exp) forearms during local temperature manipulations during normothermia and 
hyperthermia (ΔTre +1.1°C). Significant differences are within the same arm and core temperature phase. aSignificantly different than 
normothermic A1 (p < 0.05). bSignificantly different from normothermic B1 (p < 0.05). cSignificantly different than normothermic A2 (p < 0.05). 
dSignificantly different than hyperthermic B1 (p < 0.05). eSignificantly different than hyperthermic A1 (p < 0.05). fSignificantly different than 
hyperthermic B2 (p < 0.05). 
 Normothermia  Hyperthermia 
 A1 B1 A2 B2  B1 A1 B2 A2 
T̅con 33.3 ± 0.1 33.2 ± 0.1 33.2 ± 0.1 33.0 ± 0.1a  33.1 ± 0.1 33.0 ± 0.1 33.0 ± 0.1 33.1 ± 0.1 
T̅exp 33.2 ± 0.1 38.3 ± 0.1a 32.5 ± 0.2b 38.8 ± 0.1abc  38.6 ± 0.1 33.4 ± 0.1d 38.7 ± 0.1e 33.2 ± 0.1df 
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Figure 10. Representative data from one participant. The top panel is the skin blood flow 
responses, in cutaneous vascular conductance as a percentage of max, of the control (filled 
circles; CVCcon) and experimental (open circles; CVCexp) arms. ‘A1’ and ‘A2’ represent the 
neutral (33°C) experimental arm temperature (T̅exp) manipulations, and ‘B1’ and ‘B2’ represent 
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the hot (38.5°C) T̅exp manipulation. The bottom panel has T̅exp (open circles), control (filled 
circles; T̅con), mean skin (open upward triangles; T̅sk), and core (filled downward triangles; Tre) 
temperature responses to local and whole-body temperature manipulations. 
5.2 Local Temperature Effects During Normothermia on Skin Blood Flow 
5.2.1 Laser-Doppler Flowmetry (PU) 
During normothermia, LDF data of the experimental arm changed with each Tloc 
manipulation (p < 0.001), whereas control arm LDF data remained constant (p = 0.148). 
See Table 5 for LDF data of the experimental and control arm during each measurement 
phase throughout normothermia. 
Table 5. Laser-Doppler flowmetry units (PU) for the experimental and control arm responding to 
local temperature changes during normothermia. aSignificantly different from A1 (p < 0.05).  
bSignificantly different from B1 (p < 0.05). cSignificantly different from A2 (p < 0.05).   
 Experimental  Control 
 A1 B1 A2 B2  A1 B1 A2 B2 
LDF (PU) 
10.8 
±0.7 
53.3 
±3.5a 
18.7 
±2.9b 
45.6 
±4.6ac 
 7.3 
±0.8 
8.3 
±1.4 
8.2 
±1.4 
8.7 
±1.2 
 
The ∆PUexp (Fig. 11B) from A1 to B1 was +42.5 ± 3.8 PU. Decreasing T̅exp from 
B1 to A2, ∆PUexp was -34.6 ± 4.8 PU (p < 0.001). Finally, increasing T̅exp from A2 to B2, 
∆PUexp was +26.9 ± 3.4 PU (p = 0.002 vs. A1 to B1, p < 0.001 vs. B1 to A2).  
5.2.2 Cutaneous Vascular Conductance (%max) 
During normothermia, CVC of the experimental arm changed with each Tloc 
manipulation (p < 0.001), whereas it remained constant for the control arm (p = 0.172). 
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See Table 6 for CVC data of the experimental and control arm during each measurement 
phase throughout normothermia. 
Table 6. Cutaneous vascular conductance (CVC) expressed as percent of maximum for the 
experimental and control arm during normothermia in response to local temperature 
manipulations. aSignificantly different from A1 (p < 0.05). bSignificantly different from B1 (p < 
0.05). cSignificantly different from A2 (p < 0.05).   
 Experimental  Control 
 A1 B1 A2 B2  A1 B1 A2 B2 
CVC (%max) 
10.8 
±1.6 
51.3 
±6.6a 
18.2 
±3.3b 
43.6 
±6.1ac 
 8.5 
±1.1 
9.6 
±1.6 
9.4 
±1.6 
10.1 
±1.4 
 
The ∆CVCexp (Fig. 11A) from A1 to B1 was +40.5 ± 5.6 %max. Decreasing T̅exp 
from B1 to A2, ∆CVCexp was -33.1 ± 5.9 %max (p < 0.001). Finally, increasing T̅exp from 
A2 to B2, ∆CVCexp was +25.4 ± 4.0 %max (p = 0.002 vs. A1 to B1, p < 0.001 vs. B1 to 
A2).  
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Figure 11. Changes to CVC (A) and LDF (B) from Tloc manipulations during normo- (filled 
circles) and hyper-thermia (open circles). *Significantly different from hyperthermic measures (p 
< 0.05). aSignificantly different from A1-B1 (p < 0.05). bSignificantly different from B1-A2 (p < 
0.05). cSignificantly different from A2-B2 (p < 0.05). 
5.3 Local Temperature Effects During Hyperthermia on Skin Blood Flow 
5.3.1 Laser-Doppler Flowmetry (PU) 
During hyperthermia, LDF data of the experimental arm (p < 0.001) changed with 
each Tloc manipulation, whereas control arm LDF data decreased (p = 0.001). See Table 7 
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for LDF data of the experimental and control arm during each measurement phase 
throughout hyperthermia. 
Table 7. Laser-Doppler units (PU) for the experimental and control arm during hyperthermia in 
response to local temperature manipulations. aSignificantly different from B1 (p < 0.05).  
bSignificantly different from A1 (p < 0.05). cSignificantly different from B2 (p < 0.05).   
 Experimental  Control 
 B1 A1 B2 A2  B1 A1 B2 A2 
LDF (PU) 
78.5 
±11.9 
71.7 
±10.3a 
76.0 
±10.7b 
66.9 
±9.1abc 
 48.1 
±4.5 
44.7 
±3.8a 
46.8 
±4.0b 
44.0 
±3.5ac 
 
∆PUexp (Fig. 11B) during hyperthermia are presented in the same order as 
normothermia (A1 to B1, B1 to A2, and A2 to B2). ∆PUexp between A1 and B1 was +6.8 
± 1.9 PU. ∆PUexp between B1 and A2 was -11.6 ± 3.1 PU (p = 0.015). Finally, ∆PUexp 
concerning A2 and B2 was +9.1 ± 1.9 PU (p = 0.064 vs. A1 to B1 p = 0.007 vs. B1 to 
A2). 
∆PUexp between A1 and B1 during normothermia was 35.7 ± 3.9 PU greater (p < 
0.001) than hyperthermia. The ∆PUexp between B1 to A2 during normothermia was 
greater than hyperthermia (-23.0 ± 4.8 PU; p = 0.001). The final ∆PUexp between A2 to 
B2 was 17.8 ± 3.8 PU greater (p = 0.001) than hyperthermia.  
5.3.2 Cutaneous Vascular Conductance (%max) 
During hyperthermia, CVC of the experimental arm (p < 0.001) changed with 
each Tloc manipulation, whereas it remained constant for the control arm (p = 0.001). See 
Table 8 for CVC data of the experimental and control arm during each measurement 
phase throughout hyperthermia. 
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Table 8. Cutaneous vascular conductance (CVC) expressed as a percent of maximum for the 
experimental and control arm during hyperthermia in response to local temperature 
manipulations. aSignificantly different from B1 (p < 0.05). bSignificantly different from A1 (p < 
0.05). cSignificantly different from B2 (p < 0.05).   
 Experimental  Control 
 B1 A1 B2 A2  B1 A1 B2 A2 
CVC (%max) 
61.9 ± 
5.6 
56.7 ± 
5.0a 
60.6 ± 
5.1 
53.4 ± 
4.7abc 
 50.8 ± 
5.1 
47.1 ± 
4.2a 
49.3 ± 
4.5b 
46.5 ± 
4.2ac 
 
∆CVCexp (Fig. 11) during hyperthermia are presented in the same order as 
normothermia (A1 to B1, B1 to A2, and A2 to B2). ∆CVCexp between A1 and B1 was 
+5.2 ± 1.0 %max. ∆CVCexp between B1 and A2 was -8.5 ± 1.4 %max (p = 0.001). 
Finally, ∆CVCexp concerning A2 and B2 was +7.2 ± 1.3 %max (p = 0.186 vs A1 to B1 p 
< 0.001 vs B1 to A2). 
∆CVCexp between A1 and B1 during normothermia was 35.3 ± 5.6 %max greater 
(p < 0.001) than hyperthermia. The ∆CVCexp between B1 to A2 during normothermia 
was greater than hyperthermia (-24.7 ± 6.0 %max; p = 0.003). The final ∆CVCexp 
between A2 to B2 was 18.2 ± 3.7 %max greater (p = 0.001) than hyperthermia.  
5.3.3 Polynomial Contrasts 
A linear trend component accounted for the greatest amount of the variance 
during normothermic assessment for Tre (95.65%), whereas a quadratic trend component 
explained most of the variance for T̅sk (92.31%). T̅exp variance during normothermia was 
explained by cubic (80.82%) and linear (18.24%) trend components. Likewise, the 
variance accounting for CVCexp was explained by cubic (76.46%) and linear (18.55%) 
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trend components. As both CVCexp and T̅exp were explained with similar linear and cubic 
trends, one can infer that CVCexp is closely related to T̅exp during normothermia. 
Table 9. Polynomial trend components between normo- and hyper-thermic assessment. During 
normothermia, the variance of the trend components explaining T̅exp was similar to the variance 
trend components of CVCexp. However, during hyperthermia, the variance explaining CVCexp was 
not similar to any other trend component specifically. 
 Normothermia (VAR(p-value))  Hyperthermia (VAR(p-value)) 
 Tc T̅sk T̅exp CVCexp  Tc T̅sk T̅exp CVCexp 
Linear 
96% 
(0.006) 
0.38% 
(0.965) 
18.24% 
(<0.001) 
18.25% 
(0.002) 
 
97.82% 
(0.002) 
84.62% 
(0.367) 
20.89% 
(<0.001) 
51.72% 
(0.001) 
Quadratic 
0.0% 
(0.591) 
92.31% 
(0.089) 
0.94% 
(<0.001) 
4.99% 
(0.001) 
 
0.0% 
(0.343) 
0.0% 
(0.780) 
0.07% 
(0.140) 
2.35% 
(0.060) 
Cubic 
0.0% 
(0.468) 
0.0% 
(0.604) 
80.82% 
(<0.001) 
76.49% 
(<0.001) 
 
1.75% 
(0.121) 
7.69% 
(0.610) 
79.04% 
(<0.001) 
45.93% 
(0.001) 
 
A linear trend component accounted for the greatest amount of the variance 
during hyperthermic assessment of Tre (97.82%) and T̅sk (84.62%). The variance 
explaining CVCexp during hyperthermic assessment was explained by linear (51.72%), 
cubic (45.93%) and quadratic (2.35%) trend components. Since CVCexp and T̅exp were not 
similar, as they were during normothermia, it can be inferred that the linear trends 
composing Tre or T̅sk influenced CVCexp.  
5.4 Wavelet Analysis 
See Table 10 for the power spectra for the wavelet analysis of the control arm 
during normo- and hyper-thermia. Analysis of the vasomotion data of the control arm 
revealed no differences in the frequencies associated with endothelial (p = 0.714), NO-
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independent (p = 0.245), NO-dependent (p = 0.825), neurogenic (p = 0.863) and cardiac 
(p = 0.359) function between normo- and hyper-thermia. Frequency domains associated 
with myogenic (p = 0.034) and respiratory (p = 0.017) function increased from normo- to 
hyper-thermia.  
See Table 11 for the power spectra of the experimental arm during normo- and 
hyper-thermia during each temperature manipulation. Analysis of the vasomotion data of 
the experimental arm during normo- or hyper-thermia revealed no significant differences 
for the frequencies domains associated with endothelial, neurogenic, or cardiac function, 
or the myogenic frequency band during hyperthermia. During normothermia, the A1 
manipulation was significantly less than B1 (p < 0.001), A2 (p < 0.001), and B2 (p = 
0.006) for the myogenic band, and A1 was significantly less than B1 (p = 0.036) and B2 
(p = 0.015) for the respiratory band. During hyperthermia only the respiratory frequency 
band had the A2 manipulation less than the B1 manipulation (p = 0.045). 
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Table 10. Spectral analysis of the control arm during normo- and hyper-thermic assessment. Data 
are presented as mean ± S.E.M. aEndothelial band divided into two subsections. bSignificantly 
different from normothermia (p < 0.050). 
  Wavelet Transform (AU) 
Physiological 
function 
Frequency interval (Hz) Normothermia 
 
Hyperthermia 
Endothelial 0.0095 – 0.02 0.241 ± 0.063  0.275 ± 0.062 
     NO-Independenta        0.005 – 0.01a 0.154 ± 0.034  0.222 ± 0.036 
     NO-Dependenta        0.01 – 0.02a 0.256 ± 0.072  0.278 ± 0.064 
Neurogenic 0.02 – 0.05 0.343 ± 0.052  0.354 ± 0.035 
Myogenic 0.05 – 0.15 0.504 ± 0.092  0.857 ± 0.115b 
Respiratory 0.15 – 0.6 0.414 ± 0.092  0.738 ± 0.099b 
Cardiac 0.6 – 2.0 0.610 ± 0.142   0.786 ± 0.119 
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Table 11. Spectral analysis of the experimental arm during each temperature manipulation during normo- and hyper-thermic assessment. 
aSignificantly different from A1 (p < 0.050). bSignificantly greater from B1 (p < 0.050). cSignificantly different from normothermia (p < 0.050). 
Physiological 
Function 
Frequency interval 
(Hz) 
Normothermia 
(AU) 
 
Hyperthermia 
(AU) 
A1 B1 A2 B2  B1 A1 B2 A2 
Endothelial 0.0095 – 0.02 
0.296 
±0.088 
0.647 
±0.125 
0.376 
±0.057 
0.377 
±0.067 
 
0.483 
±0.235 
0.285 
±0.037 
0.212 
±0.029c 
0.213 
±0.023c 
Neurogenic 0.02 – 0.05 
0.508 
±0.183 
0.692 
±0.214 
0.680 
±0.286 
0.827 
±0.344 
 
0.446 
±0.068 
0.507 
±0.104 
0.369 
±0.078 
0.327 
±0.045 
Myogenic 0.05 – 0.15 
0.282 
±0.028 
0.631 
±0.054a 
0.708 
±0.063a 
0.762 
±0.109a 
 
0.906 
±0.188 
0.751 
±0.112c 
0.751 
±0.149 
0.681 
±0.102 
Respiratory 0.15 – 0.6 
0.217 
±0.039 
0.472 
±0.069a 
0.431 
±0.096 
0.514 
±0.075a 
 
0.775 
±0.130c 
0.681 
±0.112c 
0.746 
±0.170 
0.594 
±0.115b,c 
Cardiac 0.6 – 2.0 
0.310 
±0.067 
0.673 
±0.096 
0.526 
±0.078 
0.623 
±0.084 
 
0.719 
±0.140 
0.713 
±0.133c 
0.753 
±0.158 
0.696 
±0.131 
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CHAPTER SIX: DISCUSSION 
The primary objectives of this study were to isolate the contributions of Tre and 
Tloc on SkBF by manipulating normo- and hyper-thermia (∆Tre +1.1°C) and examine the 
interaction between local and reflexive SkBF control. The unique aspect of this study 
were the A-B-A-B Tloc manipulations that occurred during two distinct core temperatures, 
which provided insight into the relationship between local and reflexive SkBF control 
mechanisms. The primary finding was that high core temperatures elicited strong 
vasodilation even in a limb where local skin temperature was clamped at thermoneutral 
(33°C) throughout the experiment (57). Overall, peripheral afferents drove forearm CVC 
during normothermia, whereas central afferents attenuated the effect of Tloc 
manipulations on forearm CVC during hyperthermia, suggesting that high Tre can 
override peripheral afferents. These data support that deviations in core temperatures 
(either hot or cold) have the ability to override peripheral afferents’ control of many 
physiological variables (24, 29, 33, 57, 83, 109). 
Hyperthermia elicited reflexive vasodilation equating to ~50% of maximal CVC 
in the control arm, suggesting that central afferents can override peripheral afferents 
governing forearm SkBF. Tloc of the control arm was maintained at thermoneutral to 
assess the isolated effect of high core temperatures, while minimizing the influence of 
local control mechanisms on forearm SkBF. Similarly, Johnson et al. (57) passively 
heated participants while clamping one arm at thermoneutral, and the other heated to 
42.5°C by spraying water of the desired temperatures. Passive heat stress elicited 
vasodilation in the thermoneutral arm equal to- or slightly less than- the heated arm (57). 
The authors concluded that reflexive vasodilation still occurs in a thermoneutral limb, 
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and that there is not a synergistic effect from combining local heating with whole-body 
heating on forearm SkBF. The aforementioned study maintained thermoneutrality by 
spraying 32°C water on the forearm and assessed SkBF via plethysmography (57). 
Plethysmography is a discontinuous assessment of forearm blood flow and cannot 
distinguish between skin and muscle blood flow. The current study immersed the forearm 
into a tightly controlled water bath to create a more powerful heat sink than local 
spraying, which allowed us to maintain strict Tloc of the control arm throughout. We 
assessed forearm SkBF via laser-Doppler flowmetry, which is limited to the skin, not 
influenced by underling tissue (96), and allowed for continuous assessment of SkBF. 
Therefore, the current findings expand the work from Johnson et al. (57) by using a more 
powerful heat sink than water spraying, and manipulating Tloc during normo- and hyper-
thermia to assess how local and reflexive control of SkBF interact opposed to 
maintaining constant Tloc. 
Peripheral afferents drove forearm SkBF during normothermia, as increases in 
Tloc were followed by a subsequent increase in forearm CVC. Previous work during 
normothermia has shown similar responses, with comparable (3, 17) and higher (3, 57, 
105, 116, 117) Tloc increases facilitating vasodilation. When the skin was locally heated 
during normothermia, CVC transiently increased to 40 – 50% of maximum, however, 
vasodilation did not last the duration of the manipulation (see section 6.2, Experimental 
Considerations, for further discussion about the transient nature of the vasodilation). 
Local heating induced vasodilation is mainly a product of eNOS (71) and EDHF (8), 
among other local factors (58, 59, 81). Rapid local heating (+0.1°C·s-1) to 39°C produces 
a plateau approximately 50% of maximal CVC that is largely NO-dependent (17). 
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Therefore, the vasodilation in the experimental arm that was observed during 
normothermia was likely due to NO, however this speculation remains to be tested. Local 
control mechanisms rapidly adapt with temperature changes (11, 69, 81) to protect 
underlying structures and to resist systemic temperature fluctuations. Rapid responses to 
local skin heating from 40°C to 42°C (45, 69, 81) or to 44°C (11) demonstrate that the 
local vasculature is able to quickly adapt to protect itself. Thus, local control mechanisms 
can function without changes in Tc or T̅sk, suggesting the body is able to locally 
thermoregulate (13, 58, 112).  
Previous investigations of the relationship between local and reflexive SkBF 
control have been limited in methodology, since no Tloc manipulations have occurred 
during hyperthermia to examine the interaction of local and reflexive control mechanisms 
governing forearm SkBF. It was shown that central afferents attenuate local control of 
forearm SkBF during hyperthermia, whereas peripheral afferents have greater influence 
during normothermia. The A-B-A-B Tloc manipulations had a significantly lower effect 
on forearm SkBF during whole-body hyperthermia, as demonstrated by decreased 
changes in CVC magnitude during hyper- compared to normo-thermia. The increased 
SkBF from reflexive vasodilation and the decreased magnitude of CVC changes at 
hyperthermia from the Tloc manipulations allow for the inference that high Tre attenuate 
local control mechanisms of SkBF. During heat stress, the body activates mechanisms to 
dissipate heat to the surrounding environment via conductive and evaporative pathways 
to limit heat gain (90, 111). Passive heating elicits cutaneous vasodilation to increase 
convective heat exchange with the environment (93, 111). Reflexive vasodilation occurs 
when Tloc remains thermoneutral (57, 105), however, we were the first to demonstrate 
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that this reflexive vasodilation attenuates the ability to locally control SkBF during 
hyperthermia via the A-B-A-B Tloc manipulations.  
Studies that used liquid conditioned garments as a method to control T̅sk and Tre 
often leave the SkBF measurement site uncovered (46, 112, 113). If the thermal 
background of the measurement site is not controlled, SkBF may be affected by local 
control mechanisms (33, 97). During pilot work, we observed an increase in Tloc of the 
control arm once Tre began to rise, even though it was in a ~33°C water bath. Since 
ambient temperature (22.0°C – 23.3°C) was lower than the water temperature used for 
the control arm, the upward drift in Tloc was a result of warm blood being sent to the 
extremities from reflexive vasodilation (93). Therefore, Tloc is likely to drift upwards 
from passive heating if it is not tightly regulated. The current design allowed us to 
maintain strict control of Tloc by consistently adding cool water into the water bath to 
maintain Tloc at 33°C, ensuring that if vasodilation occurred, it would be from reflexive 
vasodilation and not be influenced by local mechanisms.  
An unexpected observation was the increased MAP with passive heat stress from 
86 ± 1 mm Hg during normothermia to 94 ± 2 mm Hg during hyperthermia. Previous 
work (22) has shown a reduction of MAP following passive heat stress, however, 
participants in the study were supine and blood pressure was measured at heart level via 
the brachial artery. By design, brachial artery blood pressure was not desirable as both 
arms were being used to assess SkBF and we did not want to initiate reactive hyperemia 
(77) from the occlusion. Participants sat semi-recumbent, which allowed the site of 
measurement on their arms to be approximately heart level. With participants seated 
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during heat stress, MAP has been shown to increase (83, 84, 109). The semi-upright 
posture of the participants was likely to activate baroreceptors and cause an increase in 
blood pressure (95). Blood pressure measurements were assessed at the ankle, which was 
approximately 25 cm below heart level, which likely increased pressure due to 
differences in hydrostatic pressures (95). Also, due to venous pooling in the legs from 
vasodilation, baroreceptors were possibly activated due to a lack of central blood volume 
(62).  
6.1 Spectral Analysis 
To our knowledge, changes to the power spectral density of SkBF from passive 
heating have not been previously investigated.  Increases in power spectral density in the 
control arm from normo- to hyper-thermia were associated with myogenic and 
respiratory activity. Myogenic activity is a measure of the rhythmic oscillations that 
respond to changes in intra-arterial pressure (6, 103). During hyperthermia, reflexive 
vasodilation occurs increasing the amount of blood being sent to the extremities, which is 
represented via increased laser-Doppler units and increase amplitude in the laser-Doppler 
signal. Which are both responsible for the increased myogenic activity. The respiratory 
band is associated with changes in pressure that occur during breathing (6, 103). 
Although it was not measured, hyperthermic induced hyperpnea, occurs during passive 
heat stress (39) and the increase power in the respiratory band is likely a result of 
increased depth of breathing. 
During normothermia, myogenic activity of the experimental arm increased 
following B1 and remained elevated throughout normothermic assessment. Again, this 
was likely due to the increase in SkBF during the ‘B’ manipulation and observing many 
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more oscillations (6, 103). Interestingly, spectral density of the signal remained elevated 
during A2 assessment even though CVC returned to near baseline levels. This may be a 
result of the arterioles having an increased rate of contraction from the previous B1 
manipulation, despite the blood flow decrease during A2. Also, during normothermia, 
respiratory activity increased during B1 and B2. We did not measure breathing rate, but it 
is logical to assume that it may have risen with increasing Tloc to increase activity of this 
band (39). During hyperthermic assessment the respiratory band was lower during the 
last block (A2) compared to the first block (B1). Endothelial function was lower during 
B2 and A2 of hyper- compared to normo-thermia. This suggests that the increased CVC 
observed during hyperthermia was not locally mediated (76). It is speculated that 
hyperpnea occurred during hyperthermia and accounted towards the increased respiratory 
activity (39). In addition, the cardiac band appeared to be higher during hyperthermia; 
however, it did not reach statistical significance. 
6.2 Conclusions 
The current study sought to investigate the relative roles of Tc and Tloc on forearm 
SkBF during normo- and hyper-thermia, and how reflexive and local control mechanisms 
of forearm SkBF interact. Clamping Tloc of the control arm at thermoneutral throughout 
the experiment provided insight into reflexive vasodilation without being influenced by 
local control mechanisms. During passive heat stress, reflexive vasodilation occurred in 
the thermoneutral arm and supported previous findings (57) that reflexive vasodilation is 
able to occur in a thermoneutral background. To examine how reflexive and local control 
mechanisms interacted, Tloc of the experimental arm was manipulated during two distinct 
core temperature phases. Manipulating Tloc during normothermia significantly affected 
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CVCexp as it mirrored changes to T̅exp. During hyperthermia, Tloc manipulations had 
significantly less effect on CVCexp, suggesting that the mechanisms involved with 
reflexive vasodilation elicited from high Tre attenuate local control on SkBF. These data 
indicate that SkBF responds greater to Tloc changes during normo- compared to hyper-
thermia.  
6.3 Experimental Considerations 
A young and fit population (7 males and 3 females; 20 – 26 years old; 52.1 – 69.2 
mL·kg-1·min-1) was used to determine how local and reflexive control mechanisms 
interact to govern forearm SkBF. We did not include adolescents as they demonstrate 
decreased sweating ability and increased SkBF compared to adults (28), (78, 94), or older 
adults as they have lower SkBF response to passive heat stress (47, 82). Aerobic fitness is 
directly related to the magnitude of the SkBF response to local heating (47). Therefore, 
our results may not be generalizable to less fit populations or those significantly older or 
younger than the studied population.  
The vasodilatory responses of the experimental arm were transient during the ‘B’ 
manipulations (Tloc = 38.5°C; i.e., vasodilation did not last the entire ‘B’ manipulation), 
and it has been demonstrated that local heating to higher temperatures elicits further 
vasodilation (3, 57, 105, 116, 117). Therefore, it is possible that local heating to 38.5°C 
was not severe enough to warrant vasodilation for the duration of local heating. The 
approximate rate of heating achieved in the current study was ~3°C·min-1, which is 
commonly used throughout local heating protocols (25, 41, 42). This heating rate is 
characterized by an initial peak occurring within the first 5 min, succeeded by a brief 
portion of nadir, and then a prolonged plateau taking longer to establish (17, 58, 59). It is 
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possible that the transient vasodilatory response observed during normothermia was the 
initial peak and nadir portions of local heating, before the plateau began to establish.  
Wavelet analysis was performed in order to gain a mechanistic understanding of 
what was facilitating vasodilation during normothermia, and what mechanisms were 
hindering local SkBF control during hyperthermia. Due to the transient nature of the 
vasodilatory response (only lasting 30 – 60 s) to the Tloc manipulations, we were unable 
to get reliable data using wavelet analysis. The reason for needing a prolonged period of 
time to analyse blood flow dynamics is that they are composed of slow moving, 
nonstationary components (6, 76, 103). The endothelial band is found as slow as 0.0095 
Hz, taking ~105 s to complete one cycle. Recently this band has been further separated to 
a frequency of 0.005 Hz (76), taking 200 s to complete one oscillation. It has been 
suggested that 30 min is needed to accurately analyse this component of SkBF (75, 76) 
Since we were unable to attain stable laser-Doppler data during the Tloc manipulations, 
we were unable to reliably perform wavelet analysis, as we would be analysing less than 
one complete cycle for the slower components of SkBF. 
6.4 Future Directions 
To delineate whether the attenuated local control of SkBF was a function of 
elevated T̅sk or Tre, Tloc manipulations can be done during different levels of heat stress. 
At the onset of passive heating, there is a lag time between increasing T̅sk and the 
subsequent increase in Tre. If Tloc manipulations were to be performed during this time, it 
would delineate whether Tre or T̅sk is the force during heat stress that attenuates local 
control of SkBF, and how each of their respective control mechanisms interact. Also, 
mild heat stress (∆Tre +0.5°C), which would be more indicative of a real world heat stress 
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from work, sporting events, or prolonged heat exposure, might demonstrate more local 
control providing insight to what type of relationship exists between local and reflexive 
control. If the observed decrease in local control of SkBF was a function of high Tre, this 
would determine if the decreased local control was a graded or an ‘all-or-none’ response.  
The current study observed local temperature changes between neutral and hot 
Tloc while participants were normo- or hyper-thermic. Vasoconstriction during local 
heating has been demonstrated during lower-body negative pressure (57), but not during 
whole-body heat stress with local cooling. Local skin cooling could determine at which 
point during heat stress vasoconstrictor function becomes compromised. This study could 
be replicated with a focus on hypo- instead of hyper-thermia to determine if local heating 
can cause vasodilation during whole-body cold stress. This would provide insight into 
how the body protects core temperature from cold stress. 
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APPENDIX A 
Informed Consent:  
 
Project Title: The isolated and synergistic effect of core body and skin temperature on forearm 
skin blood flow (EEL-093). 
 
Principal Investigator:  
Dr. Stephen Cheung, Ph.D. (Professor) 
Department of Kinesiology 
Brock University                                          
905-688-5550 x 5662, scheung@brocku.ca 
Principal Student Investigator: 
Matthew Mallette (M.Sc. Candidate) 
Department of Kinesiology 
Brock University                                          
905-688-5550 x 4901, mm09pk@brocku.ca 
 
Co-Investigator 
Dr. Gary Hodges, Ph.D. (Adjunct Professor) 
Department of Kinesiology 
Brock University 
905-688-5550 x 4901, ghodges@brocku.ca 
 
 
INVITATION 
You are invited to participate in a study that involves research if you are a healthy male or female 
18-35 years old. The purpose of this study is to examine the influence of whole body 
hyperthermia on skin blood flow when forearm temperature is hot (38.5°C) compared to when it is 
maintained in a thermoneutral state (33°C). 
 
WHAT’S INVOLVED 
There will be a total of two sessions. During the first session you will be screened for 
participation, provide anthropometric measurements, a treadmill VO2peak test, as well as be 
familiarized with the study’s equipment. The second session will be experimental session.  
 
At the familiarization session, you will have your height, weight, body fat, and aerobic fitness 
measured. Body fat testing will be performed using skinfold calipers, which might cause a slight 
pinching sensation, and will be taken by someone of the same sex in a private room. You will 
exercise on a motorized treadmill at a gradually increasing incline until exhaustion in order to 
obtain your peak oxygen uptake (VO2peak) and maximum heart rate (HRmax). These tests will be 
used to describe the subject pool in published reports. Time for this session is about 1 hour. 
 
At the start of the experimental session, you will change into a t-shirt and shorts. Following this, 
you will have your internal temperature measured by inserting a rectal temperature sensor as well 
as provide a urine sample to assess your hydration status. The rectal sensor consists of a very 
thin and flexible plastic tube that you insert 15 cm beyond the anus. Appropriate change rooms 
will be provided for you to change into the required clothing, and insert the rectal thermometer. 
Skin temperature will be monitored using sensors taped to ten sites on your body. A heart rate 
chest strap and watch will continuously monitor your heart rate. Your blood pressure will be 
measured throughout the experiment with a manual blood pressure cuff placed around your lower 
right leg (just above the ankle). You will be asked remove your shirt (females will be asked to 
wear a sports bra) and will be instrumented with a heart rate strap and skin thermistors before 
putting on a liquid conditioning garment (LCG), which is similar to a diving wet suit lined with 
flexible PVC tubing throughout. The garment consists of a pair of pants, jacket, and hood, leaving 
the face, hands, forearms and feet uncovered. During the experiments, warm (49°C) water will be 
run through the tubing to raise skin and core temperature. You will have a skin blood flow sensor 
attached with tape to each of your forearms. 
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During each session you will be asked to sit in a chair that has water troughs in place of arm 
rests. A baseline measurement will occur by sitting in the chair and the LCG will maintain a 
thermoneutral environment for ~20 minutes by circulating ~32°C water throughout the LCG until 
mean body skin temperature stabilizes at 33°C. A blood pressure measurement will be taken 20 
minute intervals throughout the experimental session. This is similar to when a doctor takes blood 
pressure. Over the next 26 minutes, water temperature for one forearm will be rapidly changed 
between 33°C and 38.5°C in five minute intervals, and the other forearm will be kept at a constant 
temperature of 33°C. Blood pressure measurements will be taken before and after each 
temperature manipulation. Then warm water (49°C) will be pumped through the LCG to increase 
your core temperature by 1.2°C. The temperature of the water in the LCG will then be adjusted to 
keep your core temperature stable. Again, over the next 26 minutes, skin temperature of one 
forearm will be rapidly changed between 38.5°C and 33°C in five minute intervals, and the other 
forearm will be kept at a constant temperature of 33°C. Following this last forearm temperature 
manipulation, skin temperature of the areas under the laser-Doppler probe will be raised to 44°C 
for ten minutes in order to elicit a maximal skin blood flow response. You will be asked to remain 
in the laboratory for 30 minutes to ensure that you are symptom-free after the experiment has 
concluded. Total time commitment for the session is about 3.5 hours. 
 
POTENTIAL BENEFITS AND RISKS 
Possible benefits of participation include a free body composition test, normally costing $50, and 
a free VO2peak test, normally costing $100 - $150. You will also receive $50 for participating in the 
experimental session. 
 
There may be risks associated with participation. The exercise (VO2peak) test is an “all-out” effort 
that is performed to exhaustion. You may feel quite tired for up to 48 h after the test. There is a 
very remote risk of heart attack or stroke when exercising to exhaustion, but this is minimized with 
the use of the health screening questionnaire, as well as the monitoring of HR during the test. 
There will be at least two investigators trained in First Aid and CPR present for each experiment. 
The investigators will contact you later the same day following each session to check on your 
health status, so we will need a current phone number to do so. 
 
Experimental sessions will be terminated if: 
1. Core temperature rises above 40.0°C. 
2. Systolic blood pressure drops below 80 mmHg for more than 1 min. 
3. You decide, for any reason, to end the experiment. 
4. The investigators determine that you are unable/unfit to continue. 
 
Hyperthermia 
Symptoms that may be experienced with hyperthermia include: discomfort, sweating, 
flushing and redness in the face and body, thirst, loss of fine motor coordination due to sweating, 
minor mental confusion, dizziness, nausea and a drop in blood pressure. Given the level of 
hyperthermia employed in the proposed study (skin temperature of ~38.5°C, core temperature of 
~38.2°C to 38.5°C), it is very unlikely that any serious symptoms would arise (as core 
temperature will not rise above 39.0°C). In event of intolerable symptoms, the heating protocol 
would be terminated immediately, followed by the circulation of cold water through the LCG, 
allowing for the rapid return of skin to normothermic levels. This typically removes most of any 
unpleasant feelings with the heating. Water will be available to you throughout. You will be in a 
reclined and seated position throughout the experiment, so there is no chance of you falling in the 
unlikely case that you become dizzy or faint. 
 
Other Risks 
The use of skin fold calipers may cause a slight pinching sensation. All skin fold measurements 
will be taken in a private room by an investigator of the same sex. The body sites for skin fold 
measurements are triceps, subscapula, mid-axilla, supra-illiac crest, chest, abdomen and thigh. 
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There is also a chance that surface temperature sensors or tape use with these sensors may 
cause some skin irritation, although this adverse response is rare. Alternative adhesive options 
are available if needed. 
 
If you experience any unusual symptoms after completing a testing session, you should 
immediately seek medical attention and inform Dr. Cheung. The investigators will also contact 
you later the same day of your participation to ensure that you are in a healthy state. Depending 
on your health status, you may be asked to consult with a physician. 
 
RECTAL PROBE 
Insertion of the flexible rectal probe may cause slight discomfort. You will be given instruction 
about how to prepare the probe, and will self-insert the probe in a private room. You will be 
provided with water-based lubricant if necessary, and will secure the probe with a soft gauze 
“sumo sling” harness, which will keep it in place during the experiment.   
 
When performed in a healthcare setting, insertion of the rectal probe is a controlled act as set out 
in the Regulated Health Professions Act. While this act does not extend to research outside of a 
healthcare setting, you should be aware of the following potential risks: 
 Insertion of the rectal probe can stimulate the vagus nerve which can cause slowing of 
the heart rate which may lead to fainting. This is more likely to happen if you have a low 
resting heart rate. 
 Perforation of the bowel can lead to peritonitis, a serious infection of the abdominal 
cavity, though the investigators are unaware of this ever occurring in a research setting. 
 
You should not participate in this research if you are under the influence of alcohol or other 
sedating substances (tranquilizers, sleeping pills, street drugs) or have any history of fainting or 
heart disease. 
 
CONFIDENTIALITY 
Investigators will require disclosure of your name and contact information (phone, email), and 
therefore your participation is not anonymous during the conduct of the research. All participants 
will have their names removed from any data and a participant ID number used instead. The 
master list matching participants to data will be kept by the listed researchers, and will be 
destroyed following data collection and giving you your own and the group’s average results. 
 
All information you provide is considered confidential; your name will not be included or, in any 
other way, associated with the data collected in the study. Furthermore, because our interest is in 
the average responses of the entire group of participants, you will not be identified individually in 
any way in written reports of this research.  
 
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary. If you wish, you may decline to answer any questions or 
participate in any component of the study. Further, you may decide to withdraw from this study at 
any time and may do so without any penalty or loss of benefits to which you are entitled. This can 
be done in-person, through e-mail (Matt Mallette, mm09pk@brocku.ca; Dr. Stephen Cheung, 
scheung@brocku.ca) or through telephone (Dr. Stephen Cheung, 905-688-5550x5662). 
Participation, non-participation, or withdrawal from the study will not affect your standing at Brock 
University. 
 
PUBLICATION OF RESULTS 
Results of this study may be published in professional journals and presented at conferences, but 
your personal information and participation will remain confidential. Feedback about this study will 
be available from Dr. Stephen Cheung (scheung@brocku.ca, 905-688-5550x5662). 
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CONTACT INFORMATION AND ETHICS CLEARANCE 
If you have any questions about this study or require further information, please contact the 
Principal Investigator using the contact information provided above. This study has been 
reviewed and received ethics clearance through the Research Ethics Board at Brock University 
(13-283). If you have any comments or concerns about your rights as a research participant, 
please contact the Research Ethics Office at (905) 688-5550 Ext. 3035, reb@brocku.ca.  
 
 
CONSENT FORM 
 
The isolated and synergistic effect of core body and skin temperature on forearm skin 
blood flow (EEL-093). 
 
I agree to participate in this study described above. I have made this decision based on 
the information I have read in this Informed Consent Letter. I have had the opportunity to receive 
any additional details I wanted about the study and understand that I may ask questions in the 
future. I understand that I may withdraw this consent at any time by telling or writing Drs. Cheung 
or Hodges or Mr. Mallette. My participation, non-participation, or withdrawal from the study will not 
affect my standing at Brock University.  
 
Participant Name:     ___________________________       
  
 
Participant Signature:    ___________________________      Date:    
______________________ 
  
 
Principal Investigator: Stephen S. Cheung, Ph.D. 
 
Principal Investigator Signature:  ___________________________      Date:    
______________________ 
 
 
Thank you for your assistance in this project. Please keep a copy of this form for your records. 
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APPENDIX A 
The isolated and synergistic effect of core body skin temperature and 
skin temperature on forearm skin blood flow (EEL-093) 
Environmental Ergonomics Laboratory Fitness Screening Form 
Please read over the questions below*. They are to assist in assessing whether you are fit to 
participate in this study. Please ask the investigators if you have any queries while filling out the 
form. 
Screening Questions* YES NO 
1. Has your doctor ever said that you have a heart condition and that you 
should only do physical activity recommended by a doctor? 
  
2. Do you feel pain in your chest when you do physical activity?   
3. In the past month, have you had chest pain when you were not doing 
physical activity? 
  
4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
  
5. Do you have a bone or joint problem (for example, back, knee or hip) that 
could be made worse by a change in your physical activity? 
  
6. Is your doctor currently prescribing drugs (for example, water pills) for your 
blood pressure or heart condition? 
  
7. Do you know of any other reason why you should not do physical activity?   
8. Current pregnancy or menstrual irregularities (e.g., loss of cycle) in 
females? 
  
9. Do you have any bowel or prostate problems (e.g. colitis, irritable bowel 
syndrome, prostate problems) 
  
10. Neuromuscular (e.g., epilepsy, Multiple Sclerosis, Cerebral Palsy), skeletal 
(e.g., inflammatory or degenerative arthritis) or circulatory (e.g., diabetes, 
hypertension) disorders? 
  
11. Do you have a tendency for, or ever been diagnosed with, claustrophobia 
(a very strong fear of confined spaces)? 
  
Name: ________________________________________  
Signature ______________________________________
 Date**________________________ 
